cefixime has been researched along with Hemolysis in 1 studies
Cefixime: A third-generation cephalosporin antibiotic that is stable to hydrolysis by beta-lactamases.
cefixime : A third-generation cephalosporin antibiotic bearing vinyl and (2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-[(carboxymethoxy)imino]acetamido groups at positions 3 and 7, respectively, of the cephem skeleton. It is used in the treatment of gonorrhoea, tonsilitis, pharyngitis, bronchitis, and urinary tract infections.
Hemolysis: The destruction of ERYTHROCYTES by many different causal agents such as antibodies, bacteria, chemicals, temperature, and changes in tonicity.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Imran, M | 1 |
| Shah, MR | 1 |
| Ullah, F | 1 |
| Ullah, S | 1 |
| Sadiq, A | 1 |
| Ali, I | 1 |
| Ahmed, F | 1 |
| Nawaz, W | 1 |
1 other study available for cefixime and Hemolysis
| Article | Year |
|---|---|
Double-tailed acyl glycoside niosomal nanocarrier for enhanced oral bioavailability of Cefixime.
Topics: Animals; Biological Availability; Cefixime; Drug Carriers; Drug Liberation; Female; Glycosides; Hemo | 2017 |